Cite
HARVARD Citation
Pires da Silva, I. et al. (2021). Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. Lancet oncology. 22 (6), pp. 836-847. [Online].